NASDAQ: CERECerevel Therapeutics Holdings Inc Stock Ownership - Who owns Cerevel Therapeutics Holdings?
Insider buying vs selling
Have Cerevel Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| N. Anthony Coles | Director | 2024-04-01 | 50,000 | $3.50 | $175.00kBuy |
| N. Anthony Coles | Director | 2024-04-01 | 50,000 | $42.33 | $2.12MSell |
| N. Anthony Coles | Director | 2024-03-04 | 50,000 | $41.01 | $2.05MSell |
| N. Anthony Coles | Director | 2024-03-04 | 50,000 | $3.50 | $175.00kBuy |
| N. Anthony Coles | Director | 2024-02-29 | 50,000 | $41.16 | $2.06MSell |
| N. Anthony Coles | Director | 2024-02-29 | 50,000 | $3.50 | $175.00kBuy |
| N. Anthony Coles | Director | 2024-02-07 | 2,506 | $41.54 | $104.11kSell |
| John Renger | Chief Scientific Officer | 2024-02-07 | 2,161 | $41.54 | $89.78kSell |
| N. Anthony Coles | Director | 2024-01-02 | 50,000 | $3.50 | $175.00kBuy |
| N. Anthony Coles | Director | 2024-01-02 | 50,000 | $42.24 | $2.11MSell |
CERE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CERE insiders and whales buy or sell their stock.
CERE Shareholders
What type of owners hold Cerevel Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Christopher R. Gordon | 69.57% | 126,315,419 | $5.31B | Insider |
| Adam Koppel | 69.57% | 126,315,419 | $5.31B | Insider |
| Bain Capital Investors LLC | 69.56% | 126,312,137 | $5.31B | Insider |
| Bain Capital Investors LLC | 36.17% | 65,679,781 | $2.76B | Institution |
| Pfizer Inc | 14.40% | 26,149,211 | $1.10B | Insider |
| Perceptive Advisors LLC | 6.04% | 10,965,193 | $461.31M | Institution |
| Perceptive Advisors LLC | 5.95% | 10,794,876 | $454.14M | Insider |
| Fmr LLC | 5.34% | 9,691,851 | $407.74M | Institution |
| Avoro Capital Advisors LLC | 4.16% | 7,555,555 | $317.86M | Institution |
| Vanguard Group Inc | 4.06% | 7,374,970 | $310.26M | Institution |
CERE vs Biotech Stocks
Cerevel Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.